From GM, re Ivermectin:

“My wife and I attended a memorial in NY for her sister who passed in May 2022 from pancreatic cancer. Her sister had been the principal of a local school in Westchester County and was a very popular figure both from the school and her involvement in charity work. Consequently, hundreds turned out for the service that was held in a large ballroom at a yacht club along the Hudson. Still, the room wasn’t large enough. Walking into the room, I commented that ‘this was a super-spreader event if ever I saw one.’ Well, just two days later, at the same time, we both came down with Omicron. Having very closely followed the entire COVID landscape for over two years, every day reading the latest medical papers, protocols, and developments, I was fully aware of the worldwide random control trials involving Ivermectin. No lie, I have at least 1,000 hours in research time on this subject. My doctor cut me off and refused to continue a conversation/ debate over many COVID-related topics. I think he realized he didn’t stand a chance. As a result of this knowledge, I secured, early on, a supply of Ivermectin which I put into our ‘drug inventory’ in the cool, dry basement. At the first sign of symptoms, I broke out the COVID tests and IVM and followed the FLCCC protocol. 

“My recovery time was three days and my wife’s was five. Blood type matters in COVID. I am universal O but she is A. The data has indicated that those with type A have a more serious case with more symptoms and more severe reactions. Our firsthand experience bears out the data. The one lingering aspect, after the three and five days, was an annoying dry cough for several weeks. No big deal.

“Interestingly, both IVM and Pfizer’s Paxlovid are protease inhibitors. This is the mechanism utilized by both to terminate the proliferation of the virus. Very simply, the virus dies in the presence of the inhibitor. Early treatment is key to cutting off virus replication! So, why did Pfizer bring out Paxlovid rather than allow IVM to do the work? Patent $$$! IVM is generic and safe without the now well-known rebound effect of Paxlovid. IVM received the Nobel Prize in 2015 and it may well become recognized as a miracle drug since studies show overwhelming effectiveness against cancers and other viruses such as AIDS and influenza. All this with a drug that safely allows use with a wide dosage tolerance. You can be way off on the dose without harming yourself. But, if you were to ask the FDA, NIH, or CDC, they would tell you bumpkins to stay away from that there horse dewormer! Isn’t it just great? Pfizer gets to make billions on a ‘vaccine’ (Wait… NOT really a vaccine!) and when it fails completely sell you the newly patented drug Paxlovid since they can make no $$$ on producing IVM. Gotta love it!”

My Response: Wow! The work you’ve done researching this is impressive. I wish I had the time to dig in deeper.

From Murzban Shroff, author of one of the “Book Recommendations for 2022” that I listed here: 

“A small note to say: I stumbled upon your website here, which lists one of my recent books, Third Eye Rising, as a recommendation – and I was quite blown away to learn of your accomplishments and interests. Would you, by any chance, be based in New York or California? The reason I ask is: I will be visiting the US this fall on a reading tour and would consider it an honor to meet you. We could discuss our mutual love for books and literature and our individual journeys. Mine has been an interesting one: from corporate life to the literary, including intense persecution that brought my life and family under threat. Either way, I am very pleased to have known of you and wish you the best in your endeavors. I am Mumbai-based, so should you ever visit, please don’t hesitate to call.”